AAAAAA

   
Results: 1-13 |
Results: 13
SUITABILITY AND LIMITATIONS OF POINTER-BASED AND MICROSCOPE-BASED NEURONAVIGATIONAL SYSTEMS FOR SURGICAL-TREATMENT OF INTRACEREBRAL TUMORS - A COMPARATIVE-STUDY OF 66 PATIENTS
Authors: SOBOTTKA SB SCHACKERT G STEINMETZ A
Citation: Sb. Sobottka et al., SUITABILITY AND LIMITATIONS OF POINTER-BASED AND MICROSCOPE-BASED NEURONAVIGATIONAL SYSTEMS FOR SURGICAL-TREATMENT OF INTRACEREBRAL TUMORS - A COMPARATIVE-STUDY OF 66 PATIENTS, Onkologie, 21(2), 1998, pp. 137-142
TRANSMISSION OF GLIOBLASTOMA-MULTIFORME THROUGH LIVER-TRANSPLANTATION
Authors: FRANK S MULLER J BONK C HAROSKE G SCHACKERT HK SCHACKERT G
Citation: S. Frank et al., TRANSMISSION OF GLIOBLASTOMA-MULTIFORME THROUGH LIVER-TRANSPLANTATION, Lancet, 352(9121), 1998, pp. 31-31
EVIDENCE THAT TSG101 ABERRANT TRANSCRIPTS ARE PCR ARTIFACTS
Authors: HAMPL M HAMPL J PLASCHKE J FITZE G SCHACKERT G SAEGER HD SCHACKERT HK
Citation: M. Hampl et al., EVIDENCE THAT TSG101 ABERRANT TRANSCRIPTS ARE PCR ARTIFACTS, Biochemical and biophysical research communications (Print), 248(3), 1998, pp. 753-760
INTRAOPERATIVE FACIAL-NERVE MONITORING (IFNM) PREDICTS FACIAL-NERVE OUTCOME AFTER RESECTION OF VESTIBULAR SCHWANNOMA
Authors: SOBOTTKA SB SCHACKERT G MAY SA WIEGLEB M REISS G
Citation: Sb. Sobottka et al., INTRAOPERATIVE FACIAL-NERVE MONITORING (IFNM) PREDICTS FACIAL-NERVE OUTCOME AFTER RESECTION OF VESTIBULAR SCHWANNOMA, Acta neurochirurgica, 140(3), 1998, pp. 235-242
MULTIPLE INTRACEREBRAL HEMANGIOBLASTOMAS IN IDENTICAL-TWINS WITH VONHIPPEL-LINDAU-DISEASE - A CLINICAL AND MOLECULAR STUDY
Authors: SOBOTTKA SB FRANK S HAMPL M SCHACKERT HK SCHACKERT G
Citation: Sb. Sobottka et al., MULTIPLE INTRACEREBRAL HEMANGIOBLASTOMAS IN IDENTICAL-TWINS WITH VONHIPPEL-LINDAU-DISEASE - A CLINICAL AND MOLECULAR STUDY, Acta neurochirurgica, 140(3), 1998, pp. 281-285
GENE-THERAPY FOR GLIOBLESTOME MULTIFORME - IN-VIVO TUMOR TRANSDUCTIONWITH THE HERPES-SIMPLEX THYMIDINE KINASE GENE FOLLOWED BY GANCICLOVIR
Authors: STOCKHAMMER G BROTCHI J LEBLANC R BERNSTEIN M SCHACKERT G WEBER F OSTERTAG C MULDER NH MELLSTEDT H SEILER R YONEKAWA Y TWERDY K KOSTRON H DEWITTE O LAMBERMONT M VELU T LANEUVILLE P VILLEMURE JG RUTKA JT WARNKE P LASEUR M MOOIJ JJA BOETHIUS J MARIANI L MEYER M BRANDLI C FREI K KONU D GIANELLABORRADORI A
Citation: G. Stockhammer et al., GENE-THERAPY FOR GLIOBLESTOME MULTIFORME - IN-VIVO TUMOR TRANSDUCTIONWITH THE HERPES-SIMPLEX THYMIDINE KINASE GENE FOLLOWED BY GANCICLOVIR, Journal of molecular medicine, 75(4), 1997, pp. 300-304
NEURONAVIGATION - THE GENTLE WAY OF REMOVING BRAIN-TUMORS
Authors: SOBOTTKA SB STEINMETZ A SCHACKERT G
Citation: Sb. Sobottka et al., NEURONAVIGATION - THE GENTLE WAY OF REMOVING BRAIN-TUMORS, Onkologie, 20(5), 1997, pp. 362-370
THE PUTATIVE TUMOR-SUPPRESSOR GENE FHIT AT 3P14.2 IS RARELY AFFECTED BY LOSS OF HETEROZYGOSITY IN PRIMARY HUMAN BRAIN-TUMORS
Authors: FRANK S MULLER J PLASCHKE J HAHN M HAMPL J HAMPL M PISTORIUS S SCHACKERT G SCHACKERT HK
Citation: S. Frank et al., THE PUTATIVE TUMOR-SUPPRESSOR GENE FHIT AT 3P14.2 IS RARELY AFFECTED BY LOSS OF HETEROZYGOSITY IN PRIMARY HUMAN BRAIN-TUMORS, Cancer research, 57(13), 1997, pp. 2638-2641
MALIGNANT GLIOMAS OF THE BRAIN AND SURGICAL LIMITATIONS
Authors: STEINMETZ A SCHACKERT G
Citation: A. Steinmetz et G. Schackert, MALIGNANT GLIOMAS OF THE BRAIN AND SURGICAL LIMITATIONS, Onkologie, 19(1), 1996, pp. 6-14
GENE-THERAPY - APPROACHES FOR THE TREATMENT OF MALIGNANT GLIOMAS
Authors: SCHACKERT G FRANK S SCHACKERT HK
Citation: G. Schackert et al., GENE-THERAPY - APPROACHES FOR THE TREATMENT OF MALIGNANT GLIOMAS, Onkologie, 19(1), 1996, pp. 16-22
LOSS OF HETEROZYGOSITY (LOH) IN BREAST-CA NCER SUSCEPTIBILITY GENES (BRCA1, BRCA2, AT, P53) IN BREAST CARCINOMAS AND THEIR METASTASES
Authors: HAMPL M HAMPL J FRANK S HAHN M NAGEL M OCKERT D SCHACKERT G SAEGER HD SCHACKERT HK
Citation: M. Hampl et al., LOSS OF HETEROZYGOSITY (LOH) IN BREAST-CA NCER SUSCEPTIBILITY GENES (BRCA1, BRCA2, AT, P53) IN BREAST CARCINOMAS AND THEIR METASTASES, Langenbecks Archiv fur Chirurgie, 1996, pp. 201-204
COMBINED DETECTION OF CD44 ISOFORMS BY EXON-SPECIFIC RT-PCR AND IMMUNOHISTOCHEMISTRY IN PRIMARY HUMAN BRAIN-TUMORS AND BRAIN METASTASES
Authors: FRANK S RIHS HP STOCKER W MULLER J DUMONT B BAUR X SCHACKERT HK SCHACKERT G
Citation: S. Frank et al., COMBINED DETECTION OF CD44 ISOFORMS BY EXON-SPECIFIC RT-PCR AND IMMUNOHISTOCHEMISTRY IN PRIMARY HUMAN BRAIN-TUMORS AND BRAIN METASTASES, Biochemical and biophysical research communications, 222(3), 1996, pp. 794-801
ACTIVATED MONOCYTES KILL MALIGNANT BRAIN-TUMOR CELLS IN-VITRO
Authors: KIRSCH M FISCHER H SCHACKERT G
Citation: M. Kirsch et al., ACTIVATED MONOCYTES KILL MALIGNANT BRAIN-TUMOR CELLS IN-VITRO, Journal of neuro-oncology, 20(1), 1994, pp. 35-45
Risultati: 1-13 |